Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06015165Recruiting
Pain control plan for complex anorectal surgery
This study tests a pain management plan led by anesthesiologists for people having complex anorectal surgery. The goal is to see if this approach can better control pain and improve recovery.
Beijing, Beijing MunicipalityAges 18–85 - NCT06345118Recruiting
Fall prevention for older adults with type 2 diabetes
This trial studies a fall prevention program for older adults with type 2 diabetes. The goal is to see if it reduces falls and improves safety.
HanoiAges 60–60 - NCT07652892Recruiting
Fatty Liver, Memory, and Health in Men and Women
This study looks at how fatty liver disease (related to metabolism) affects memory, strength, and quality of life—especially comparing men and women. It helps understand why some people with fatty liver feel more tired or have trouble thinking clearly.
Barcelona, BarcelonaAges 20–80 - NCT07654634Enrolling by invitation
Precision blood thinning therapy study
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
Changsha, HunanAges 8 years+ - NCT07651176Enrolling by invitationPhase 2/Phase 3
Comparing three chemotherapy approaches for newly diagnosed AML
This study tests three different chemotherapy regimens (LDA, LHAA, and DA) in adults aged 18–65 with newly diagnosed acute myeloid leukemia (AML, a blood cancer). The goal is to find which approach works best and is safest for patients fit enough for intensive treatment.
Hangzhou, ZhejiangAges 18–65 - NCT07651163Enrolling by invitationPhase 2/Phase 3
Comparing three chemotherapy regimens for newly diagnosed blood cancer
This trial tests three different chemotherapy regimens for adults 15–65 years old with newly diagnosed acute myeloid leukemia (AML)—a serious blood cancer. The goal is to see which treatment approach works best for patients with intermediate or high-risk disease who are fit enough for intensive chemotherapy.
Hangzhou, ZhejiangAges 15–65 - NCT07650760RecruitingPhase 4
Pain Relief After Gallbladder Removal Surgery
This trial tests whether flushing the abdomen with a numbing medication (bupivacaine) during minimally invasive gallbladder surgery reduces pain after the procedure compared to using saline (salt water) alone.
Wāh, Punjab ProvinceAges 18–60 - NCT07652775Recruiting
Brain stimulation and exercise for memory and mood
This study tests whether combining rTMS (a non‑invasive brain stimulation) with aerobic exercise can improve memory, thinking, and mood in older adults who have mild memory problems and depression. It may offer a safe, drug‑free way to help both brain health and emotional well‑being.
Taipei, Taipei CityAges 65–90 - NCT07653035Recruiting
Can a weighted blanket help with anxiety during cancer treatment?
This study tests whether using a weighted blanket during intravenous cancer therapy (like chemo or immunotherapy) can reduce anxiety, stress, and depression, and increase comfort. It also checks if nurses find it easy to use.
Muscat, SeebAges 18 years+ - NCT07649616Enrolling by invitation
Training Law Enforcement to Use Heart-Restart Devices
This study helps police officers learn to use automated external defibrillators (AEDs)—machines that can restart a stopped heart during cardiac emergencies. The goal is to increase how often these devices are used and improve survival rates when officers respond to cardiac arrest calls.
Detroit, MichiganAges 18 years+ - NCT07653984Recruiting
Study on immune diseases in women of childbearing age
This study follows women with certain immune disorders affecting the nervous system (like multiple sclerosis or myasthenia gravis) to understand how these conditions affect reproduction. Healthy women planning pregnancy are also included for comparison.
Guangzhou, GuangdongAges 20–55 - NCT07650877Recruiting
Pain relief blocks for minimally invasive chest surgery
This study compares two different types of nerve blocks (numbing injections near the ribs) to see which one works better for pain relief after minimally invasive chest surgery. Both techniques are standard care options, and the trial will help doctors understand which one provides the best pain control.
Çankaya, AnkaraAges 18–75 - NCT07653711Recruiting
Coated aldehyde oxystarch for reducing toxins in kidney failure
This trial tests a new oral medication, coated aldehyde oxystarch, for people on dialysis. It aims to lower certain waste products in the blood that are hard to remove with standard dialysis, which may help reduce long-term complications.
BeijingAges 18 years+ - NCT07653659Recruiting
Lowering norepinephrine in shock: effects on blood vessel pressure
This study tests whether reducing the dose of a medicine that raises blood pressure (norepinephrine) affects how blood moves through the body in people with distributive shock. If you are on a steady low dose of norepinephrine and have a special heart monitor (PiCCO catheter), this trial may help doctors understand safer ways to wean the medicine.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07650435Recruiting
Clot removal in pulmonary embolism trial
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
PlymouthAges 18 years+ - NCT07649161Recruiting
Nicotinamide Riboside and Brain Energy in Healthy Adults
This study tests whether a vitamin B3-like supplement called nicotinamide riboside can improve how your brain uses energy. Researchers will use brain imaging and blood tests to see if it helps brain function in healthy adults.
Boston, MassachusettsAges 18–65 - NCT07652879RecruitingPhase 2
KCD drug combination for newly diagnosed POEMS syndrome
This trial tests a combination of three drugs (carfilzomib, cyclophosphamide, and dexamethasone) for people newly diagnosed with POEMS syndrome. It aims to see how well this treatment helps control the disease and its symptoms.
ShanghaiAges 18–75 - NCT07646730Recruiting
Wearable Watch to Detect Complications After Lung Surgery
This study tests whether a wearable device (a smartwatch-like device) worn after lung or chest surgery can help doctors catch complications early by monitoring your heart rate, activity, and other vital signs. The goal is to catch problems sooner so you can get help faster.
Wuhan, HubeiAges 18 years+ - NCT07648823RecruitingEarly Phase 1
New radioactive treatment for recurrent brain tumors
This early-stage trial tests a new radioactive drug called [177Lu]Lu-XT771 injected directly into the brain cavity after glioblastoma surgery. It measures whether the drug is safe and helps slow tumor regrowth in patients whose cancer has come back after earlier treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT07649109RecruitingPhase 4
Heart Device Detected Irregular Heartbeats: Treatment Study
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
TaipeiAges 18 years+ - NCT07648082Recruiting
Understanding Breathlessness in Lung Disease
This study explores how people experience and perceive breathlessness, whether they have a known lung condition or are healthy. Researchers want to understand breathlessness better to potentially improve how it's managed and treated.
Leicester, LeicestershireAges 18–100 - NCT07653321Enrolling by invitation
Kidney injury in critically ill patients
This study looks at acute kidney injury in patients who are very sick in the intensive care unit (ICU). It may help doctors better understand and manage kidney problems in these patients.
BeijingAges 18 years+ - NCT07647094RecruitingPhase 2
Chemotherapy plus immunotherapy for advanced squamous lung cancer
This trial tests a combination of three drugs—two chemotherapy medications (carboplatin and nab-paclitaxel) plus an immunotherapy drug (serplulimab)—as a first-line treatment for advanced squamous cell non-small cell lung cancer. The goal is to see if this combination works better than standard treatment and is safe for patients who haven't received prior systemic cancer treatment.
Quzhou, ZhejiangAges 18–75 - NCT07652138RecruitingPhase 1
RN1201 injection for newly diagnosed multiple myeloma
This trial tests a new drug called RN1201 as a first-line treatment for multiple myeloma, a blood cancer. The study aims to see if it is safe and effective for patients who have never been treated for this condition before.
Suzhou, JiangsuAges 18–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,202 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.